Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy. [electronic resource]
Producer: 20190828Description: 5089-5102 p. digitalISSN:- 1543-8392
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- chemistry
- Cell Line, Tumor
- Cetuximab -- chemistry
- Cross-Linking Reagents -- chemistry
- Docetaxel -- chemistry
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Immunoconjugates -- chemistry
- Mice
- Mice, Nude
- Neoplasms -- drug therapy
- Panitumumab -- chemistry
- Survival Analysis
- Tissue Distribution
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.